Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 4.57% is 71% below its 5-year average of 15.69%, near the low end of its 5-year range (4.57%–108.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 78.95% below its 12-month average of 21.72%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.57%.
DEBT TO ASSETS RATIO
4.57%
DEBT TO ASSETS RATIO AVG TTM
21.72%
DEBT TO ASSETS RATIO AVG 3Y
19.78%
DEBT TO ASSETS RATIO AVG 5Y
15.69%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-78.95%
CURRENT VS 3Y AVG
-76.89%
CURRENT VS 5Y AVG
-70.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+4978.62%
vs the sector median at left
Q32 Bio Inc.
Market Cap
$241.39M
Debt to Assets Ratio
4.57%
TTM Avg
21.72%
3Y Avg
19.78%
5Y Avg
15.69%
Market Cap
$241.34M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$241.94M
Debt to Assets Ratio
0.68%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.02M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.97M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.66M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Q32 Bio Inc. (QTTB) | $241.39M | 4.57% | 21.72% | 19.78% | 15.69% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | 0.02% | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | 0.68% | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 0.12% | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.01M | 0.33% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | 0.04% | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | 0.01% | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 0.00% | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 0.15% | N/A | N/A | N/A |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | 0.01% | N/A | N/A | N/A |
Debt/Assets
4.6%
Debt/Equity
0.05
Current Ratio
20.30
Interest Coverage
15.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 4.57% |
| 2026-03-31 | 21.43% |
| 2025-12-31 | 24.84% |
| 2025-09-30 | 29.46% |
| 2025-06-30 | 28.28% |
| 2025-03-31 | 23.77% |
| 2024-12-31 | 20.47% |
| 2024-09-30 | 18.58% |
| 2024-06-30 | 15.98% |
| 2024-03-31 | 13.23% |
| 2023-12-31 | 108.04% |
| 2023-09-30 | 92.49% |
| 2023-06-30 | 16.96% |
| 2023-03-31 | 14.71% |
| 2022-12-31 | 72.41% |
| 2022-09-30 | 11.36% |
| 2022-06-30 | 8.43% |
| 2022-03-31 | 7.71% |
| 2021-12-31 | 11.30% |
| 2021-09-30 | 5.87% |
| 2021-06-30 | 5.48% |
| 2021-03-31 | 6.31% |
| 2020-12-31 | 5.86% |
| 2020-09-30 | 7.02% |
| 2020-06-30 | 6.43% |
| 2020-03-31 | 5.94% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
